News

Observe Medical – First order to Slovakia

Oslo, November 29, 2023 – Observe Medical (the "Company" or "Observe Medical") has received first order for delivery of UnoMeter Abdo Pressure products from our distributor in Slovakia, Unomed.   The UnoMeter portfolio is rapidly extending its reach and with the addition of Slovakia, we have now secured orders from a total of 16 countries. With…

Read more

Observe Medical ASA – Invitation to a Company presentation 4 December 2023

Oslo, 29 November 2023 – Observe Medical ASA (OSE: OBSRV) (the “Company" or "Observe Medical") will host a Company presentation Monday 4 December 2023, at 13:00 CET. The presentation will take place virtually on Microsoft Teams Live Event, and is hosted by SpareBank 1 Markets. Please use the following link to join www.bit.ly/OBSRV23 (https://eur03.safelinks.protection.outlook.com/?url=httpwww.bit.lyOBSRV23&data=0501perarne.nygardobservemedical.comffccd96ce09a4a65ebb808dbefeb08dc139dbc03ecf246efb467a338c990a8d600638367564980273081UnknownTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn03000&sdata=9CZ7I1MkfbxrBhwzeMxEcPdP1AGrmZQwHXmugcC33U&reserved=0). The presentation…

Read more

Observe Medical – New order and distribution agreement with ReplantMed

Oslo, November 28, 2023 – Observe Medical ("the Company" or "Observe Medical") announces a new order and distribution agreement with ReplantMed, our Hungarian distributor. The UnoMeter portfolio is continuously expanding footprint with total orders from 15 countries, demonstrating its widespread market and global demand. Positive clinical evaluations further strengthen the quality and performance of the UnoMeter…

Read more

OBSERVE MEDICAL ASA – Commencement of the subscription period for the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF…

Read more

Observe Medical ASA: Receipt of subscription rights in the rights issue by primary insiders and close associates

Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 22 November 2023, regarding the extraordinary general meeting's approval of the contemplated rights issue raising gross proceeds of up to NOK 55 million (the "Rights Issue"). Reference is further made to the stock exchange announcement published on 24 November…

Read more

OBSERVE MEDICAL ASA – Updated ticker code and ISIN for the subscription rights

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF…

Read more

OBSERVE MEDICAL ASA – Extraordinary general meeting held

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF…

Read more

OBSERVE MEDICAL ASA – Updated key information relating to the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF…

Read more

OBSERVE MEDICAL ASA – Terms of the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF…

Read more

Observe Medical ASA: Correction of attachments to notice of extraordinary general meeting in connection with the proposed rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF…

Read more

Observe Medical – UnoMeter orders continue to come in from both new and existing customers and the geographical footprint is expanding

Oslo, November 10, 2023 – Observe Medical ("the Company" or "Observe Medical") has received follow-up orders from several distributors including the Spanish distributor, BM2 Health, for delivery of UnoMeter Abdo Pressure products, with most recent follow-up orders having a value of approx. NOK 1,3 million. The total value of orders for the UnoMeter product range has…

Read more

Observe Medical ASA – Key information relating to the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED…

Read more

Observe Medical ASA: Proposed rights issue and notice of extraordinary general meeting in connection with the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF…

Read more

Observe Medical – First shipment of UnoMeter[TM] 500 products

Oslo, October 26, 2023 – Observe Medical ("the Company" or "Observe Medical") today announces the shipment of the first UnoMeter[TM] 500 products to distributors in Poland and Spain. Containers carrying over 96,000 UnoMeterTM 500 products are now loaded at our OEM factory and set to ship on October 30th, which build upon the previous stock announcement…

Read more

Observe Medical delivers 20 new ultrasound probes to Fresenius Medical Care

Oslo, October 17, 2023 – Observe Medical (OSE: OBSRV) Observe Medical ("the Company" or "Observe Medical") today announces that it has delivered 20 Biim ultrasound probes to Fresenius Medical Care in the US. As part of the partnership agreement with Fresenius Medical Care, Observe Medical has delivered 20 Biim ultrasound probes to Fresenius Medical Care,…

Read more

Observe Medical secures new funding

Oslo, 11 September 2023 – Observe Medical ASA (the "Company" or "Observe Medical") has secured new loans with the largest shareholders totaling NOK 7.25 million (the "Loans"). The Loans will be used to finance the first instalment under the asset transfer agreement with Unomedical and running business. The Company will immediately receive payment of NOK…

Read more

Observe Medical signs milestone agreement with Unomedical

Oslo, 11 September 2023 – Observe Medical ASA ("Observe Medical" or the "Company") has, through its wholly owned subsidiary Observe Medical AS ("OMAS"), signed an asset transfer agreement with Unomedical A/S and Unomedical s.r.o. as sellers (which are ultimately owned by Convatec Group Plc) (the "ATA"), following the entry of an exclusivity agreement in October…

Read more

SECOND QUARTER AND FIRST HALF YEAR OF 2023 REPORT

Oslo, August 25, 2023 – The Board of Directors of Observe Medical ASA has approved the unaudited group financial results for the second quarter and first half year of 2023. Please find attached the Interim Report. FOR FURTHER INFORMATION, PLEASE CONTACT: Rune Nystad, CEO Observe Medical Mobile: +47 916 24 683 E-mail: rune.nystad@observemedical.com Per Arne…

Read more

OBSERVE MEDICAL – FINANCING AND COST REDUCTION ACTIVITIES

Oslo, July 4, 2023 – Observe Medical ASA ("Observe Medical" or the "Company") refers to its stock exchange notices dated 14 December 2022 and 23 March 2023, concerning, among other things, its financing plans. The stock exchange notice of 14 December 2022 concerned the proposed issuance of a NOK 30-50 million bond loan in the…

Read more

Link to the recording of the Company presentation held 6 June, 2023

Link to the recording of the live event: https://attendee.gotowebinar.com/recording/1358614173515479296 For further information, please contact:   Rune Nystad, CEO Observe Medical Mobile: +47 916 24 683 E-mail: rune.nystad@observemedical.com Per Arne Nygård, CFO of Observe Medical Mobile: +47 411 04 345 E-mail: perarne.nygard@observemedical.com About Observe Medical   Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech…

Read more

Observe Medical ASA: Invitation to a Company presentation 6 June, 2023

Oslo, 5 June 2023 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) will host a Company presentation Tuesday, 6 June 2023, at 14:00 CEST. The presentation will take place virtually on Microsoft Teams Live Event, and is hosted by SpareBank 1 Markets. Please register to corporateaccess@sb1markets.no to receive a link to join.…

Read more

Observe Medical ASA – Minutes from Annual General Meeting

Observe Medical ASA has today, May 26, 2023, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. For further information, please contact:   Rune Nystad, CEO Observe Medical Mobile:…

Read more

Observe Medical ASA – Notice of Annual General Meeting

Oslo, May 5, 2023 – Observe Medical ASA (OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, May 26, 2023, at 10:00 (CET). The annual general meeting will be held at Dronning Eufemias gate 16, 0191 Oslo for those attending in person. The Notice of the Annual General Meeting is attached.…

Read more

Observe Medical Annual Report for 2022

Oslo, 28 April 2023 – Observe Medical ASA ("the Company" or "Observe Medical") today announces that the Company has published its Annual Report for 2022. The Annual Report was approved by the Board of Directors on 27 April 2023. “In 2022, Observe Medical explored several paths to broaden our product portfolio and secure production capacity.…

Read more

Update on acquisition of Ferrari L. and Shareholder Letter

Oslo, 20 April 2023 – Observe Medical ASA ("the Company" or "Observe Medical") today announces it has informed Ferrari L., an Italian manufacturer of medical equipment, that the Company has decided to discontinue the process of acquiring Ferrari L. The contemplated acquisition was originally announced in a press release on 14 December 2022. This decision…

Read more

Observe Medical secures new financing

Oslo, March 23, 2023 – Observe Medical ASA ("Observe Medical" or "the Company") has entered into loan agreements for its short term financing needs. Further to the stock exchange announcement on 14 December 2022, the Company has entered into loan agreements where the lenders have committed to an amount of NOK 10 million. The Company…

Read more

Observe Medical ASA – Company presentation

Oslo, 6 March 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) has prepared an updated company presentation which can be found attached. The presentation is also available on www.observemedical.com For further information, please contact:   Rune Nystad, CEO Observe Medical Mobile: +47 916 24 683 E-mail: rune.nystad@observemedical.com Per Arne Nygård, CFO of Observe Medical Mobile:…

Read more

Observe Medical ASA: Status update on Letters of Intent

Oslo, 3 March 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) today provides an update on the initial letters of intent (LOIs) that have been sent to distributors of the Unometer portfolio. As previously announced, Observe Medical is in the process of confirming orders with distributors of Unometer Safeti Plus, AbdoPressure and Sippi.…

Read more

Shareholder letter

Oslo, March 2, 2023 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter. The letter to our shareholders is enclosed to this release. For further information, please…

Read more

Observe Medical ASA: Fourth quarter 2022 results

Observe Medical ASA: Fourth quarter 2022 results Oslo, 17 February 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) today releases its results for the fourth quarter of  2022. "The year 2022 has been a transformational year for Observe Medical. Building on the growth initiatives seen earlier in the year, we signed two exclusivity…

Read more

Observe Medical ASA: Invitation to fourth quarter 2022 presentation

Oslo, 10 February 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) will release its fourth quarter 2022 results on Friday, 17 February 2023. The presentation will be made available on NewsWeb and the Company's website at 07:00 CET on the same day. Rune Nystad, CEO, and Per Arne Nygård, CFO, will host a presentation…

Read more

Shareholder Letter

Oslo, January 10, 2023 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter. The letter to our shareholders is enclosed to this release. For further information, please…

Read more

Observe Medical ASA announces the appointment of Chief Commerical Officer

Oslo, 10 January 2023 – Observe Medical ASA ("the Company" or "Observe Medical") announces it has appointed Jørgen Mann as the Company’s Chief Commercial Officer. With nearly 20 years of experience in sales and senior management roles from global medtech companies in Europe, he brings highly relevant experience to Observe Medical, as the company strengthens…

Read more

Observe Medical to present at the DNB Nordic Healthcare Conference

Oslo, December 15, 2022 – Observe Medical ASA ("Observe Medical" or "the Company") today announce that Rune Nystad, CEO of Observe Medical, will present at the 13th annual DNB Nordic Healthcare Conference in Oslo, Norway, today on Thursday, December 15, 2022, at 15.35 CET. The presentation is attached to this announcement. For further information, please…

Read more

Observe Medical provides an update on contemplated financing

Oslo, 14 December 2022 – The Nordic medtech company Observe Medical ASA ("Observe Medical" or "the Company") is planning to issue a NOK 30-50 million bond loan in the first quarter of 2023, which is expected to be followed by a NOK 100-150 million equity issue around mid-year 2023. It is contemplated that the bond…

Read more

Observe Medical ASA – Grant of options

Observe Medical ASA (the "Company") has on November 11, 2022, granted 1,000,000 share options in the Company to the group CEO, Rune Nystad. The options have been granted with an exercise price of NOK 4.5 per option share. The options will west in three tranches, whereby each tranche comprising 1/3 of the options will vest…

Read more

Observe Medical ASA: Third quarter 2022 results

Oslo, 3 November 2022 – Observe Medical ASA (“the Company” or “Observe Medical”) today release its results for the third quarter of 2022. "In October, we announced that Observe Medical had entered into an exclusive agreement with the intention to acquire Convatec’s Unometer urine measurement portfolio, consisting of several market-leading brand names such as Unometer™…

Read more

Observe Medical ASA –  Invitation to third quarter 2022 presentation

Oslo, October 26, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical"or the "Company"), will release its third quarter 2022 results on Thursday, 3 November 2022. The presentation will be made available on NewsWeb and the Company’s website at 07:00 CET on the same day. Rune Nystad, CEO, and Per Arne Nygård, CFO, will host…

Read more

Shareholder Letter

Oslo, October 25, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter. The letter to our shareholders is enclosed to this release. For…

Read more

Observe Medical ASA announces appointment of Chief Technology Officer

Oslo, 9 September 2022 – Observe Medical ASA (“the Company” or “Observe Medical”), is pleased to announce the appointment of Carsten Trygve Bøgh as Chief Technology Officer (CTO), effective 2 October 2022. Mr. Bøgh has a long-standing medtech career, having led several innovative product launches, delivered impactful results, and reached value-inflection milestones for companies. “We…

Read more

Shareholder Letter

Oslo, September 5, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter (in Norwegian). The letter to our shareholders is enclosed to this…

Read more

Observe Medical ASA: Second quarter and first half year 2022 results

Oslo, 25 August 2022 – Observe Medical ASA (“the Company” or “Observe Medical”) today release its results for the second quarter and first half year of  2022. Following the acquisition of Biim Ultrasound in March 2022 and corresponding high corporate activity, Observe Medical has worked to integrate and extract operational synergies across the company and…

Read more